Latka logo
BrainChild Bio logo

BrainChild Biorevenue

Seattle, WashingtonFounded 2023CEO Steven Brugger

BrainChild Bio is a kids-first, clinical-stage biotechnology company focusing on harnessing CAR T-cell technology for tumors in the central nervous system, particularly pediatric brain tumors.

brainchildbio.comLinkedInUpdated Sep 10, 2026
Annual revenue
$7.8M
Sep 2025EST
Employees
40
Sep 2025

BrainChild Bio revenue

BrainChild Bio has not published its revenue. Growjo puts it at about $7.8M a year (September 2025).

$0
$2M
$4M
$6M
$0
–
$7.8M
202320242025
ReportedEstimateFounded 2023 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$7.8MESTGrowjo estimate

BrainChild Bio CEO & employees

Steven Brugger is CEO of BrainChild Bio. BrainChild Bio has 40 employees (September 2025, LinkedIn).

0
10
20
30
40
40
2025
ReportedOne figure per year; a reported figure wins over an estimate

BrainChild Bio FAQ

What is BrainChild Bio's revenue?

Growjo estimates BrainChild Bio's revenue at about $7.8M a year (September 2025). The company hasn't published its own figure.

How many employees does BrainChild Bio have?

BrainChild Bio has 40 employees as of September 2025, according to LinkedIn.

Who is the CEO of BrainChild Bio?

Steven Brugger is the CEO of BrainChild Bio.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun BrainChild Bio? Join the podcast